CoChat
Cited by 1,908

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

Open access
McGuigan, Andrew, Kelly, Paul, Turkington, Richard C, Jones, Claire, Coleman, Helen G, McCain, R Stephen · 2018 · World Journal of Gastroenterology

Abstract

This review aims to outline the most up-to-date knowledge of pancreatic adenocarcinoma risk, diagnostics, treatment and outcomes, while identifying gaps that aim to stimulate further research in this understudied malignancy. Pancreatic adenocarcinoma is a lethal condition with a rising incidence, predicted to become the second leading cause of cancer death in some regions. It often presents at an advanced stage, which contributes to poor five-year survival rates of 2%-9%, ranking firmly last amongst all cancer sites in terms of prognostic outcomes for patients. Better understanding of the risk factors and symptoms associated with this disease is essential to inform both health professionals and the general population of potential preventive and/or early detection measures. The identification of high-risk patients who could benefit from screening to detect pre-malignant conditions such as pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasms and mucinous cystic neoplasms is urgently required, however an acceptable screening test has yet to be identified. The management of pancreatic adenocarcinoma is evolving, with the introduction of new surgical techniques and medical therapies such as laparoscopic techniques and neo-adjuvant chemoradiotherapy, however this has only led to modest improvements in outcomes. The identification of novel biomarkers is desirable to move towards a precision medicine era, where pancreatic cancer therapy can be tailored to the individual patient, while unnecessary treatments that have negative consequences on quality of life could be prevented for others. Research efforts must also focus on the development of new agents and delivery systems. Overall, considerable progress is required to reduce the burden associated with pancreatic cancer. Recent, renewed efforts to fund large consortia and research into pancreatic adenocarcinoma are welcomed, but further streams will be necessary to facilitate the momentum needed to bring breakthroughs seen for other cancer sites.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v24.i43.4846

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 11

  1. 10.1016/j.path.2016.05.005 · DOI
  2. 10.1016/j.path.2016.05.003 · DOI
  3. 10.1043/2010-0566-RA.1 · doi:10.1043/2010-0566-ra.1
  4. Bosman FT, Carneiro F, Hruban RH TN. WHO Classification of Tumours of the Digestive System WHO Classification of Tumours of the Digestive System IARC Publications Website - WHO Classification of Tumours of the Digestive System. 2018; 2: 7-8
  5. 10.1002/1097-0142(19860515)57:10<1992::AID-CNCR2820571019>3.0.CO;2-0 · doi:10.1002/1097-0142(19860515)57:10<1992::aid-cncr2820571019>3.0.co;2-0
  6. 10.1097/SLA.0000000000002345 · doi:10.1097/sla.0000000000002345
  7. 10.1097/MPA.0b013e31824f3669 · doi:10.1097/mpa.0b013e31824f3669
  8. 10.1245/s10434-012-2823-3 · doi:10.1245/s10434-012-2823-3
  9. 10.4251/wjgo.v8.i10.745 · doi:10.4251/wjgo.v8.i10.745
  10. 10.1016/j.surg.2012.05.040 · doi:10.1016/j.surg.2012.05.040
  11. 10.1016/j.jconrel.2014.07.053 · DOI

Cited by

See all 1,908

Metadata

Authors
McGuigan, A., Kelly, P., Turkington, R. C., Jones, C., Coleman, H. G., & McCain, R. S.
Venue
World Journal of Gastroenterology
Published
2018-11-21
Volume
24
Issue
43
Pages
4846-4861
ISSN
1007-9327 (ISSN-L)
OpenAlex
W2898368508
Cited by
1,908
References
105
FWCI
48.53
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.